Drug control: the Office of National Drug Control Policy should develop key planning elements to meet statutory requirements : report to Congressional addressees
- Collection:
- Health Policy and Services Research
- Contributor(s):
- United States. Government Accountability Office. issuing body. United States. Congress. issuing body.
- Publication:
- Washington, DC : United States Government Accountability Office, December 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Drug Misuse -- legislation & jurisprudence Drug Overdose -- prevention & control Government Regulation Substance-Related Disorders -- prevention & control United States United States. Office of National Drug Control Policy
- Genre(s):
- Technical Report
- Abstract:
- Why GAO did this study. Almost 70,000 people died from drug overdoses in 2018, according to the latest Centers for Disease Control and Prevention data. The 2018 SUPPORT Act reauthorized ONDCP and imposed new requirements. GAO noted in its March 2019 High Risk report that the federal effort to prevent drug misuse is an emerging issue requiring close attention. Pursuant to 21 U.S.C. § 1708a(b), GAO has periodically assessed ONDCP’s programs and operations. This report assesses the extent to which ONDCP (1) met selected statutory requirements related to the National Drug Control Strategy in 2017, 2018, and 2019, and (2) has planned or implemented actions to meet selected new requirements in the SUPPORT Act. GAO assessed the 2019 Strategy and companion documents against four key statutory requirements that were consistent with or similar to ONDCP’s ongoing responsibilities under the SUPPORT Act. GAO also assessed ONDCP’s progress in addressing seven new SUPPORT Act requirements, and interviewed ONDCP officials. What GAO recommends. GAO is making 4 recommendations to ONDCP to develop, document, and implement key planning elements to meet certain requirements in the SUPPORT Act. ONDCP agreed to implement 2 recommendations related to the Strategy, but disagreed with 2 related to the Drug Control Data Dashboard, noting that recent updates satisfy the law. GAO maintains that they do not fully do so, and that implementing key planning elements would help address the law, as discussed in the report.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (ii, 39 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 9918284266906676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918284266906676